Keylika Analysis
What is Keylika?
Keylika specializes in drug discovery and delivery, focusing on innovative transdermal technologies. Their unique approach combines AI-enabled drug design with nanotechnology to create effective therapies. This enables the development of the first Rx skin patch for treating iron deficiency anemia, improving patient compliance and outcomes.
HQ Country
Walnut Creek, United States
Employees
1-10
Founded
2022
Industry
HealthTech, Biotech, Medical Devices
Product Features & Capabilities
- Transdermal iron patch (NistuFe) for iron deficiency anemia
- AI-enabled de novo drug design technology
- Mixed ligand metal complexes for drug synthesis
- Proven delivery technologies for optimal clinical outcomes
- Proprietary iron formulation for enhanced absorption.
